Topic: Sanofi

Sanofi and GlaxoSmithKline are seeking regulatory approval for a new COVID-19 vaccine that showed 58% efficacy in trials. Meanwhile, CDC Director Rochelle Walensky is signaling a shift toward "measured" guidance, allowing for breaks from mask-wearing as metrics improve.

Norway has officially reclassified COVID-19 as being on equal footing with the seasonal flu, removing all mandates. In the United States, pharmaceutical marketing for Fluzone High-Dose Quadrivalent targets adults over 65, claiming superior protection compared to standard flu shots.

Vaccine manufacturers have increased production by 15% to meet expected demand for flu shots. Pharmacies like CVS are offering online paperwork and drive-up shots to encourage early vaccination. The push is characterized as a strategic move by pharmaceutical PR agents to ensure quarterly profits.

Congress held hearings on the skyrocketing cost of insulin, which has risen from $21 to $275 per vial since 1996. The hosts discuss how hospitals and insurance companies negotiate lump-sum budgets and then "back-fill" individual procedure prices to meet those arbitrary totals.

Roseanne Barr's claim that her controversial tweets were the result of taking Ambien prompted a public rebuttal from the drug's manufacturer, Sanofi, stating that racism is not a known side effect. The hosts review the actual clinical side effects of the sedative, including sleepwalking, memory loss, and "emotional blunting."

Medical updates cover the symptoms and transmission of Hepatitis A, noting that the virus is rarely fatal and does not cause chronic disease. A significant warning is issued regarding Sanofi Pasteur's dengue fever vaccine, Dengvaxia, which may actually increase the risk of severe disease in people who have never been previously infected. The segment also notes the low effectiveness of the current year's flu vaccine.

Healthcare workers in Las Vegas are reportedly being forced to receive flu shots or wear surgical masks until March. This leads to a review of a real Sanofi Pasteur marketing campaign featuring "Flugitives"—characters like "the fitness fanatic" who believe they are too healthy for vaccines. The hosts analyze the use of social shaming and buzzwords in pharmaceutical advertising.

The summary covers the launch of a cholera vaccination campaign in Haiti using the drug Shanchol, developed with support from the Bill & Melinda Gates Foundation. The hosts link the outbreak to UN peacekeepers and question why a new, expensive vaccine is being used instead of traditional water and sanitation infrastructure. Additionally, a dental office poster promoting the HPV vaccine for oral cancer prevention is critiqued as a new marketing tactic.